SCHEMBL6204446

SCHEMBL6204446

COC([O])c1cccc(O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 2/20 0.47
ADRA1A P35348 2/20 0.47
MIF P14174 1/20 0.47
HTR2A P28223 1/20 0.47
HTR2B P41595 1/20 0.47
HIF1A Q16665 4/20 0.44
ADRB2 P07550 1/20 0.44
HTR1A P08908 1/20 0.44
ADRA2A P08913 1/20 0.44
ADRB3 P13945 1/20 0.44
TSHR P16473 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
NFKB1 P19838 1/20 0.44
DRD1 P21728 1/20 0.44
HTR7 P34969 1/20 0.44
ADRA1B P35368 1/20 0.44
DRD3 P35462 1/20 0.44
RAB9A P51151 1/20 0.44
SLC6A3 Q01959 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8177814 0.79 ADRB1 (0.50) ADRB1ADRA1AMIFHTR2AHTR2B
SCHEMBL27624911 0.78 MEN1 (0.46) TSHRLMNAKDM4ECYP3A4ALDH1A1
SCHEMBL18912756 0.78 ADRB1 (0.53) ADRB1ADRA1AMIFHTR2AHTR2B
SCHEMBL6204449 0.78 ADRB1 (0.53) ADRB1ADRA1AMIFHTR2AHTR2B
SCHEMBL6205041 0.78 IDO1 (0.46) GAAALDH1A1
SCHEMBL5168017 0.78 AOC3 (0.49) TSHRLMNAALDH1A1ACHE
SCHEMBL921895 0.76 ADRB1 (0.61) ADRB1ADRA1AMIFHTR2AHTR2B
SCHEMBL6202881 0.76 AOC3 (0.50) CYP3A4ALDH1A1CA2CA9POLB
SCHEMBL6204068 0.76 AOC3 (0.50) KDM4EACHE
SCHEMBL6204740 0.76 AOC3 (0.50) SLC6A3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1668601-A N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors JANSSEN PHARMACEUTICA NV (BE) 2005-09-14 CN disclosed
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed